This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other disorders involving the immune mechanism, not elsewhere classified
D3_IMMUNEMECHANISMOTHER
immune system disease: A disorder resulting from an abnormality in the immune system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1120 |
4. Check minimum number of eventsNone |
1120 |
5. Include endpoints |
1137 |
6. Filter based on genotype QC (FinnGen only) |
1137 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80-D89
- Name in latin
- Aliae perturbationes ad mechanismos immunales pertinentes non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Other disorders involving the immune mechanism, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1137 | 438 | 699 |
| Unadjusted period prevalence (%) | 0.25 | 0.15 | 0.31 |
| Median age at first event (years) | 48.58 | 42.51 | 52.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1009
- Matched controls
- 10088
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
323.0
762
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
3229.1
280.6
258
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
272.5
249
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
48.4
259.3
316
94
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
90.8
254.6
278
42
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
51.1
254.1
306
85
Z94.0
ICD-10 Finland
Kidney transplant status
73.6
214.5
242
43
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
81.1
213.1
237
38
A11CC03
ATC
alfacalcidol; systemic
41.5
212.7
268
87
L04AA06
ATC
mycophenolic acid; systemic
57.2
210.6
248
57
127
Kela drug reimbursment
Transplant complication
50.9
205.9
248
64
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
19.8
194.1
308
219
A12AA04
ATC
calcium carbonate; oral
52.3
185.3
222
54
TK800
NOMESCO Finland
Hemodialysis
35.7
181.5
237
86
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
72.8
167.8
190
32
C03CA01
ATC
furosemide; systemic
7.3
164.4
508
1235
Z49.1
ICD-10 Finland
Extracorporeal dialysis
52.8
155.5
186
43
B03XA02
ATC
darbepoetin alfa; parenteral
36.5
147.5
191
64
205
Kela drug reimbursment
Chronic hypertension
6.4
147.2
506
1367
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
49.5
140.4
170
41
N18.8
ICD-10 Finland
Other chronic renal failure
23.4
140.1
206
109
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
57.8
133.4
157
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.8
130.9
260
289
N18.0
ICD-10 Finland
End-stage renal disease
52.5
130.3
156
35
137
Kela drug reimbursment
Uraemia requiring dialysis
42.9
128.4
160
44
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.0
125.5
364
752
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
66.9
125.4
144
25
KA1AE
NOMESCO Finland
Kidney ultrasound examination
23.2
123.1
181
94
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
121.3
114
*
R80
ICD-10 Finland
Isolated proteinuria
88.8
119.6
132
17
H02AB04
ATC
methylprednisolone; systemic
6.9
118.2
342
695
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
49.5
116.4
141
33
Z49.0
ICD-10 Finland
Preparatory care for dialysis
50.5
112.8
136
31
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
46.7
112.8
138
34
B05DA
ATC
Isotonic solutions
45.7
107.4
132
33
C09AA02
ATC
enalapril; systemic
5.5
104.3
372
961
Z49.2
ICD-10 Finland
Other dialysis
53.7
103.2
123
26
M04AA01
ATC
allopurinol; systemic
6.5
102.9
307
634
L04AD01
ATC
ciclosporin; systemic
22.0
102.7
153
81
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
96.8
102.4
112
13
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.1
102.3
206
227
C08CA01
ATC
amlodipine; oral
4.4
101.7
523
1972
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
13.3
98.3
180
162
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
97.3
621
2821
V03AE01
ATC
polystyrene sulfonate; oral
33.0
90.8
120
41
B05DB
ATC
Hypertonic solutions
47.3
90.2
110
26
R31
ICD-10 Finland
Unspecified haematuria
6.8
89.2
251
469
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
85.3
434
1551
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.4
83.3
123
62
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
78.1
74
*
B03XA01
ATC
erythropoietin; parenteral
34.1
73.4
96
31
V03AE02
ATC
sevelamer; oral
43.7
71.1
88
22
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.1
69.6
167
241
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.5
66.7
154
208
196
Kela drug reimbursment
Paricalcitol and cinacalcet
46.2
66.2
81
19
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
39.1
65.6
83
23
L04AA01
ATC
[U] ciclosporin; systemic
19.8
64.7
99
55
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
34.2
62.8
82
26
TK820
NOMESCO Finland
Peritoneal dialysis
43.8
62.3
77
19
N19
ICD-10 Finland
Unspecified kidney failure
13.6
61.8
110
90
D89.9
ICD-10 Finland
Disorder involving the immune mechanism, unspecified
+∞
61.0
58
*
C02AC05
ATC
moxonidine; oral
8.3
59.8
140
192
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.7
59.5
119
124
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
48.2
59.4
72
16
ZX120
NOMESCO Finland
Intravenous
5.2
57.7
197
447
R4110
NOMESCO Finland
Physiotherapy
3.3
57.7
386
1603
R50.9
ICD-10 Finland
Fever, unspecified
4.0
55.9
257
785
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
42.8
54.8
68
17
Z3226
NOMESCO Finland
Physiotherapist
3.6
54.8
294
1023
N17.9
ICD-10 Finland
Acute renal failure, unspecified
9.6
54.5
116
135
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.2
52.1
177
397
L04AX01
ATC
azathioprine; systemic
6.8
51.5
137
226
C07AG02
ATC
carvedilol; oral
6.9
51.0
135
221
H05BX01
ATC
cinacalcet; oral
40.1
51.0
64
17
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.7
50.2
188
467
C09CA01
ATC
losartan; oral
3.3
50.2
322
1269
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
178.7
49.3
51
*
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
+∞
48.3
46
*
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
175.0
48.3
50
*
C08CA02
ATC
felodipine; oral
5.2
48.0
163
363
H02AB06
ATC
prednisolone; systemic
2.6
47.0
548
3129
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
87.6
45.3
50
6
C08CA13
ATC
lercanidipine; oral
4.1
44.5
196
565
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
44.2
178
471
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
44.1
297
1195
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
43.3
238
823
321
Kela drug reimbursment
Paricalcitol and cinacalcet
34.8
43.3
56
17
C09CA06
ATC
candesartan; oral
3.1
42.6
279
1096
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
42.4
367
1727
Z2446
NOMESCO Finland
Social worker
4.7
41.9
154
371
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
18.6
40.6
63
36
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
38.2
40.4
51
14
I10
ICD-10 Finland
Essential (primary) hypertension
2.4
40.2
569
3490
D69.0
ICD-10 Finland
Allergic purpura
24.1
40.1
57
25
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
39.8
437
2338
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
27.1
39.3
54
21
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
22.3
39.1
57
27
V03AE03
ATC
lanthanum carbonate; oral
39.5
39.1
49
13
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.8
39.0
102
163
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.2
38.7
109
192
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
38.5
215
746
M10.9
ICD-10 Finland
Gout, unspecified
4.7
36.4
132
312
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
35.9
330
1577
XW000
NOMESCO Finland
Bone marrow biopsy
6.7
35.6
94
152
RD210
NOMESCO Finland
NA
9.2
34.6
74
86
WW200
NOMESCO Finland
Immunization
7.5
34.6
84
120
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
348.1
34.1
34
*
N082, D898
ICD-10 Finland
NA
+∞
33.5
32
*
ZXA00
NOMESCO Finland
Right side
2.6
33.4
314
1508
3AC01
NOMESCO Finland
NA
19.1
33.4
51
28
M05BA04
ATC
alendronic acid; oral
5.4
32.5
102
205
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
56.3
32.5
38
7
U14
ICPC
Kidney symptom/complaint
14.5
32.4
55
40
58209
ICD-8 Finland
Chronic nephritis, Unspecified
90.5
31.9
35
*
K65.0
ICD-10 Finland
Acute peritonitis
13.1
31.6
56
45
ZXD05
NOMESCO Finland
Urgent procedure
2.4
31.6
375
2026
Z2221
NOMESCO Finland
Medical doctor
2.4
31.4
344
1783
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
31.0
145
432
TK810
NOMESCO Finland
Hemofiltration
20.0
30.7
46
24
C02CA01
ATC
prazosin; oral
11.8
30.6
57
51
ZXE00
NOMESCO Finland
One hour or less
2.2
30.5
460
2771
Z3231
NOMESCO Finland
Registered nurse
2.4
30.0
339
1777
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
311.0
29.9
30
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
7.4
29.9
73
105
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
110.0
29.8
32
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
51.6
29.5
35
7
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
29.3
221
923
D89.0
ICD-10 Finland
Polyclonal hypergammaglobulinaemia
+∞
29.3
28
*
N08.2*D57.8
ICD-10 Finland
Glomerular disorders in sickle-cell disorders
+∞
29.3
28
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
68.0
29.1
33
5
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
45.2
28.8
35
8
RS220
NOMESCO Finland
NA
10.9
28.5
55
53
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
28.3
419
2477
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
28.2
465
2883
C07AB02
ATC
metoprolol; systemic
2.7
28.1
220
938
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
43.8
27.9
34
8
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
27.6
620
7838
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
48.6
27.6
33
7
C10AA05
ATC
atorvastatin; oral
2.2
27.5
384
2206
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
54.9
27.3
32
6
D89.1
ICD-10 Finland
Cryoglobulinaemia
+∞
27.2
26
*
WX002
NOMESCO Finland
Sedation and analgesia
2.6
27.2
228
1010
R4190
NOMESCO Finland
Nutritional therapy
5.2
27.0
87
180
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.9
27.0
91
198
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
42.5
26.9
33
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.0
26.6
67
101
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
26.4
156
552
A02BC01
ATC
omeprazole; systemic
2.3
26.3
291
1491
D89.2
ICD-10 Finland
Hypergammaglobulinaemia, unspecified
+∞
26.1
25
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
26.1
250
1188
B01AB10
ATC
tinzaparin; parenteral
4.2
26.0
105
274
C02EA02
ATC
NA
6.2
25.5
70
119
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
59.6
25.1
29
5
D89.8
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
25.1
24
*
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
27.0
25.0
34
13
WW500
NOMESCO Finland
Blood transfusion
5.1
24.6
80
167
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
24.1
210
944
ZXA05
NOMESCO Finland
Left side
2.3
24.0
276
1430
WX203
NOMESCO Finland
Infraclavicular plexus blockade
7.3
23.9
58
83
C07AB07
ATC
bisoprolol; oral
2.0
23.7
442
2818
N25.0
ICD-10 Finland
Renal osteodystrophy
127.9
23.7
25
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
18.6
23.6
36
20
H02AB09
ATC
hydrocortisone; systemic
7.2
23.6
58
85
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
66.5
22.9
26
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.3
22.5
70
139
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
33.1
22.5
29
9
M10.3
ICD-10 Finland
Gout due to impairment of renal function
33.1
22.5
29
9
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.2
22.2
54
78
N08.2*D89.1
ICD-10 Finland
Glomerular disorders in cryoglobulinaemia
+∞
21.9
21
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.1
21.7
49
63
ZX108
NOMESCO Finland
Inhalation
15.7
21.6
35
23
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
21.6
111
354
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
18.3
21.0
32
18
L04AA05
ATC
[U] tacrolimus; systemic
61.3
20.9
24
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
20.9
245
1270
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
+∞
20.9
20
*
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
214.0
20.6
21
*
7910X
ICD-9 Finland
Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]
112.3
20.6
22
*
7151
FHL
Kidney transplantation
49.0
20.2
24
5
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
20.1
77
191
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.8
20.0
87
242
UKC02
NOMESCO Finland
Cystoscopy
2.4
20.0
184
845
A46
ICD-10 Finland
Erysipelas
2.6
20.0
166
722
58399
ICD-8 Finland
Nephritis, unqualified
58.7
20.0
23
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
58.7
20.0
23
*
A02BC02
ATC
pantoprazole; systemic
1.9
19.9
613
4572
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
19.9
364
2260
C10AA01
ATC
simvastatin; oral
1.9
19.8
385
2443
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
75.0
19.7
22
*
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
75.0
19.7
22
*
WW409
NOMESCO Finland
Other aferesis
40.9
19.6
24
6
XPX08
NOMESCO Finland
Intraoperative flow measurement
13.0
19.5
34
27
N02AX02
ATC
tramadol; systemic, rectal
1.9
19.4
428
2840
J01FF01
ATC
clindamycin; systemic
2.0
19.3
289
1654
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
19.2
110
379
6BA02
NOMESCO Finland
NA
46.9
19.2
23
5
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
46.9
19.2
23
5
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.2
19.2
104
345
N082, D899
ICD-10 Finland
NA
+∞
18.8
18
*
3025
Kela drug reimbursment
Calcium carbonate
28.4
18.8
25
9
J01MA02
ATC
ciprofloxacin; systemic
1.9
18.8
383
2461
I15.0
ICD-10 Finland
Renovascular hypertension
24.2
18.7
26
11
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
18.7
67
156
J01DB01
ATC
cefalexin; oral
2.0
18.6
822
6887
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
18.6
114
410
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
11.7
18.6
34
30
212
Kela drug reimbursment
Gout
6.9
18.5
46
69
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.4
18.4
68
163
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
30.7
18.4
24
8
J01MA14
ATC
moxifloxacin; systemic
3.0
18.4
114
415
N02BE01
ATC
paracetamol; systemic, rectal
2.0
18.3
821
6889
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
22.2
18.2
26
12
J01MA12
ATC
levofloxacin; systemic
2.2
18.2
207
1049
WX892
NOMESCO Finland
Monitored bed care
3.1
18.1
104
359
WX402
NOMESCO Finland
General anaesthesia
2.2
18.1
200
1000
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
17.9
133
540
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.1
17.7
56
114
UJF32
NOMESCO Finland
Coloscopy
2.0
17.5
253
1422
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
17.3
17.4
27
16
J01CA04
ATC
amoxicillin; systemic
2.0
17.4
813
6830
C10AA04
ATC
fluvastatin; oral
3.2
17.4
93
306
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
15.1
17.2
28
19
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.4
17.0
51
98
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.6
16.9
59
134
A10BH05
ATC
linagliptin; oral
4.1
16.8
67
173
H15.1
ICD-10 Finland
Episcleritis
8.6
16.8
36
43
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.9
16.6
69
185
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
91.5
16.6
18
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
172.6
16.5
17
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.9
16.3
102
372
WX610
NOMESCO Finland
Patient controlled analgesia
14.8
15.9
26
18
M10.0
ICD-10 Finland
Idiopathic gout
4.4
15.9
58
138
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
15.7
15
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
15.7
15
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
15.6
91
318
5839X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney
86.4
15.6
17
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
15.6
78
244
C08CA03
ATC
isradipine; systemic
9.6
15.5
31
33
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
15.3
212
1162
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
15.3
72
215
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
29.1
15.2
20
7
5997A
ICD-9 Finland
Other disorders of urethra and urinary tract, Haematuria
18.1
15.2
23
13
WX110
NOMESCO Finland
Local anesthesy
1.7
15.1
687
5546
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
45.7
15.1
18
*
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
32.2
14.8
19
6
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.0
14.7
89
318
ZX121
NOMESCO Finland
Central venous catheter
18.7
14.7
22
12
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
25.4
14.7
20
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
14.7
220
1240
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
14.6
14
*
N02.8
ICD-10 Finland
Recurrent and persistent haematuria, other
+∞
14.6
14
*
RS221
NOMESCO Finland
NA
6.6
14.5
37
58
H05BX02
ATC
paricalcitol; systemic
36.6
14.5
18
5
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.0
14.5
46
95
RS222
NOMESCO Finland
NA
8.4
14.3
31
38
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
14.3
106
431
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.8
14.1
35
53
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.7
14.1
48
107
C09AA05
ATC
ramipril; oral
1.9
14.0
222
1276
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
11.1
14.0
26
24
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.2
14.0
76
253
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
14.0
100
396
K06.18
ICD-10 Finland
Another gingival hyperplasia
17.8
13.9
21
12
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.9
13.8
88
324
B01AA03
ATC
warfarin; systemic
2.1
13.7
179
955
M08.2
ICD-10 Finland
Juvenile arthritis with systemic onset
76.1
13.6
15
*
U88
ICPC
Glomerulonephritis/nephrosis
76.1
13.6
15
*
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
76.1
13.6
15
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
13.6
94
364
187
Kela drug reimbursment
MPA
+∞
13.6
13
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
13.5
218
1262
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.8
13.5
58
161
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.6
13.5
61
177
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
13.4
182
986
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
13.3
166
870
N17.8
ICD-10 Finland
Other acute renal failure
9.8
13.3
26
27
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.7
13.1
57
160
B01AB04
ATC
dalteparin; parenteral
3.6
13.0
59
172
E87.5
ICD-10 Finland
Hyperkalaemia
7.1
12.9
31
45
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.7
12.9
43
94
C02DE10
ATC
NA
10.6
12.8
24
23
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
12.8
74
258
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
12.7
121
560
ZX131
NOMESCO Finland
Intrathecal
70.7
12.6
14
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
12.5
12
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
24.6
12.5
17
7
L01AA01
ATC
cyclophosphamide; systemic
24.6
12.5
17
7
WX202
NOMESCO Finland
Supraclavicular plexus blockade
6.2
12.5
33
55
TKA00
NOMESCO Finland
Needle biopsy of kidney or pelvis of kidney
131.5
12.5
13
*
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
131.5
12.5
13
*
J05AB11
ATC
valaciclovir; oral
2.2
12.4
131
636
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
11.8
12.3
22
19
M01AB05
ATC
diclofenac; systemic, rectal
0.6
12.3
387
5063
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
10.7
12.3
23
22
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
12.3
134
660
M01AH05
ATC
etoricoxib; oral
0.6
12.3
306
4223
C03AA03
ATC
hydrochlorothiazide; oral
2.6
12.3
91
370
C08CA05
ATC
nifedipine; systemic
2.9
12.2
74
264
WX204
NOMESCO Finland
Axillary plexus blockaced
4.2
12.2
46
114
B02.9
ICD-10 Finland
Zoster without complication
3.4
12.2
59
181
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
12.1
70
244
E0000UV
ATC
NA
1.7
12.1
379
2690
Z99.2
ICD-10 Finland
Dependence on renal dialysis
27.0
12.1
16
6
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
12.1
172
946
5AB14
NOMESCO Finland
NA
21.6
12.0
17
8
A12BA01
ATC
potassium chloride; oral
4.2
11.9
44
107
R06.0
ICD-10 Finland
Dyspnoea
1.8
11.9
217
1307
78930
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Haematuria
11.9
11.8
21
18
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.5
11.8
27
37
H02AB07
ATC
prednisone; oral
2.1
11.7
137
697
K65.8
ICD-10 Finland
Other peritonitis
16.6
11.7
18
11
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
30.4
11.7
15
5
WZC30
NOMESCO Finland
Teaching
2.1
11.7
136
688
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
65.7
11.6
13
*
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
65.7
11.6
13
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
65.7
11.6
13
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
11.6
62
205
WW400
NOMESCO Finland
Plasmaferesis
19.2
11.6
17
9
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
8.2
11.6
25
31
ZX112
NOMESCO Finland
Subcutaneous
5.4
11.6
34
65
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
10.2
11.5
22
22
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
10.2
11.5
22
22
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
11.5
391
2827
B07.9
ICD-10 Finland
Verruca simplex
3.7
11.5
50
141
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
11.5
11
*
5820A
ICD-9 Finland
Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]
121.2
11.4
12
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
11.3
91
387
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
7.7
11.2
25
33
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
11.2
90
382
306
Kela drug reimbursment
Erythropoietin and darbepoetin
20.3
11.1
16
8
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
11.1
105
484
B01AC04
ATC
clopidogrel; oral
2.1
11.0
138
722
SPAT1262
SPAT
Handing over of treatment supplies
1.9
11.0
176
1009
XG410
NOMESCO Finland
Flow-volume spirometry
3.5
11.0
50
147
XF402
NOMESCO Finland
ECG with work load test
2.2
10.9
112
537
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
10.8
48
138
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.5
10.8
87
369
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
18.0
10.7
16
9
L01BB01
ATC
NA
28.3
10.7
14
5
L95.8
ICD-10 Finland
Other vasculitis limited to skin
28.3
10.7
14
5
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
21.7
10.7
15
7
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
13.1
10.7
18
14
E83.51
ICD-10 Finland
Hypocalcemia
13.1
10.7
18
14
C09BA02
ATC
enalapril and diuretics; systemic
2.5
10.6
83
345
5828B
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]
111.0
10.4
11
*
M31.3
ICD-10 Finland
Wegener granulomatosis
32.9
10.3
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
10.3
108
523
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.7
10.3
275
1852
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.0
10.3
40
103
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.7
10.3
71
275
C08DB01
ATC
diltiazem; oral
3.4
10.2
48
145
TAB00
NOMESCO Finland
Lumbar puncture
3.0
10.2
58
200
JN4AD
NOMESCO Finland
Body CT examination
2.5
10.2
78
323
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
10.1
159
902
SPAT1255
SPAT
Intravenous administration of medicine
2.7
10.1
70
273
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
10.2
10.0
19
19
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
10.2
10.0
19
19
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
10.0
93
425
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
40.4
10.0
12
*
KBV10
NOMESCO Finland
Removal of stent from ureter
7.7
9.9
22
29
A02BA02
ATC
ranitidine; systemic
1.9
9.9
164
952
M10
ICD-10 Finland
Gout
3.0
9.8
56
193
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.7
189
1154
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.8
9.5
190
1173
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
9.4
76
322
TK830
NOMESCO Finland
Ultrafiltration
100.9
9.4
10
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
9.4
9
*
N08.2*D65
ICD-10 Finland
Glomerular disorders in disseminated intravascular coagulation [defibrination syndrome]
+∞
9.4
9
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
9.4
9
*
N082, D8989
ICD-10 Finland
NA
+∞
9.4
9
*
L01BB02
ATC
mercaptopurine; oral
6.1
9.2
24
40
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.1
9.2
34
84
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
9.2
134
741
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.1
9.2
48
158
C09CA07
ATC
telmisartan; oral
2.5
9.1
71
295
ED1AA
NOMESCO Finland
Mandipular X-ray examination
11.6
9.1
16
14
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
9.1
412
3145
2AX04
NOMESCO Finland
NA
37.0
9.0
11
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
37.0
9.0
11
*
ZX197
NOMESCO Finland
NA
37.0
9.0
11
*
A41.8
ICD-10 Finland
Other specified sepsis
5.3
8.9
26
50
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
18.8
8.9
13
7
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.5
8.9
25
46
UJF92
NOMESCO Finland
Capsular endoscopy
4.3
8.9
32
77
C10AA03
ATC
pravastatin; oral
2.6
8.9
65
264
E66.00
ICD-10 Finland
Metabolic syndrome
2.8
8.8
56
209
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
6.4
8.8
22
35
J01DA01
ATC
[U] cefalexin; systemic
1.5
8.8
569
4677
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.0
8.7
33
84
RS321
NOMESCO Finland
NA
50.4
8.7
10
*
GD1LA
NOMESCO Finland
GD
5.3
8.6
25
48
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.5
8.6
68
286
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.8
8.6
27
57
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
8.6
71
307
ZXA10
NOMESCO Finland
Bilateral
1.8
8.5
158
951
40399
ICD-8 Finland
Hypertensive renal disease
27.7
8.5
11
*
M13.9
ICD-10 Finland
Arthritis, unspecified
2.2
8.5
83
388
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
8.5
61
245
B05D
ATC
PERITONEAL DIALYTICS
90.7
8.4
9
*
YNB20
NOMESCO Finland
Storage of stem cells for transplant
90.7
8.4
9
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
8.4
90
441
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
12.9
8.4
14
11
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
8.3
8
*
N04.3
ICD-10 Finland
Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
8.3
8
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
8.3
8
*
N082, D890
ICD-10 Finland
NA
+∞
8.3
8
*
N082, Z940
ICD-10 Finland
NA
+∞
8.3
8
*
B01AB05
ATC
enoxaparin; parenteral
1.6
8.3
249
1715
1XC02
NOMESCO Finland
NA
9.5
8.3
16
17
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.3
403
3102
C07AG01
ATC
labetalol; systemic
7.1
8.3
19
27
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.3
8.2
29
69
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.3
8.2
39
120
T92
ICPC
Gout
4.6
8.2
27
60
K65.9
ICD-10 Finland
Peritonitis, unspecified
14.6
8.2
13
9
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
8.2
113
611
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.8
8.2
33
89
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
8.1
59
239
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
33.6
8.1
10
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
33.6
8.1
10
*
BBA50
NOMESCO Finland
Total parathyroidectomy
33.6
8.1
10
*
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
17.3
8.1
12
7
EB1WA
NOMESCO Finland
NA
9.0
8.0
16
18
TQW80
NOMESCO Finland
Local dermatologic skincare
3.5
8.0
35
101
R60.0
ICD-10 Finland
Localized oedema
2.1
8.0
94
480
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.5
7.8
16
19
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.7
7.8
53
205
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.0
7.8
18
26
L57.0
ICD-10 Finland
Actinic keratosis
2.2
7.7
78
370
N04.89
ICD-10 Finland
Nephrotic syndrome, other
45.3
7.7
9
*
WX882
NOMESCO Finland
High dependency care
2.9
7.6
44
155
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
7.6
82
402
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
18.5
7.6
11
6
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
18.5
7.6
11
6
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.1
7.6
28
70
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.8
7.6
30
80
J02AC03
ATC
voriconazole; systemic
25.2
7.6
10
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
5.2
7.6
22
43
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
6.2
7.6
19
31
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
8.9
7.6
15
17
C10AX09
ATC
ezetimibe; oral
2.0
7.5
96
505
TGC00
NOMESCO Finland
Bronchial lavation
3.7
7.5
31
86
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
7.2
7.5
17
24
D638, N189
ICD-10 Finland
NA
80.6
7.4
8
*
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.6
7.4
219
1497
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
7.4
48
183
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
7.4
47
176
XF612
NOMESCO Finland
Measurement of central venous pressure
10.9
7.3
13
12
M04AA03
ATC
febuxostat; oral
10.9
7.3
13
12
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
7.3
7
*
5829B
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,NEFR SDR]
+∞
7.3
7
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
7.3
7
*
5809A
ICD-9 Finland
Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,EI NEFR SDR]
+∞
7.3
7
*
J02AC04
ATC
posaconazole; systemic
+∞
7.3
7
*
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
+∞
7.3
7
*
N16.2*D86.8
ICD-10 Finland
Renal tubulo-interstitial disorders in sarcoidosis
+∞
7.3
7
*
NHQ40
NOMESCO Finland
Amputation of toe
5.2
7.3
21
41
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
6.3
7.3
18
29
C09CA03
ATC
valsartan; oral
2.1
7.2
75
363
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
7.2
105
580
HA1AA
NOMESCO Finland
X-ray mammography
2.6
7.1
50
199
Z85.6
ICD-10 Finland
Personal history of leukaemia
20.2
7.1
10
5
C09AA03
ATC
lisinopril; oral
2.9
7.1
41
145
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
12.1
7.1
12
10
O12.1
ICD-10 Finland
Gestational proteinuria
12.1
7.1
12
10
E21.2
ICD-10 Finland
Other hyperparathyroidism
12.1
7.1
12
10
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.1
7.1
36
118
KH1EE
NOMESCO Finland
Urologic ultrasound examination
10.1
7.0
13
13
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.3
7.0
33
102
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.7
7.0
29
81
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.9
7.0
27
71
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.0
116
669
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
7.0
152
955
ZX114
NOMESCO Finland
Intramuscular
4.5
7.0
23
52
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
7.0
69
328
WX872
NOMESCO Finland
Intensive care
2.5
6.9
52
215
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
6.9
297
2210
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.0
6.9
84
435
S97
ICPC
Chronic ulcer skin
2.5
6.9
53
223
N18
ICD-10 Finland
Chronic kidney disease
7.6
6.9
15
20
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
7.6
6.9
15
20
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
6.9
234
1653
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.8
6.9
27
72
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.9
68
323
R04.0
ICD-10 Finland
Epistaxis
2.2
6.8
68
324
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
6.8
77
387
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
8.3
6.8
14
17
J47
ICD-10 Finland
Bronchiectasis
5.1
6.8
20
40
J05AB01
ATC
aciclovir; systemic
1.6
6.8
170
1109
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
11.0
6.8
12
11
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
9.4
6.8
13
14
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
9.4
6.8
13
14
288
Kela drug reimbursment
Febuxostat
9.4
6.8
13
14
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
6.8
31
94
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
40.3
6.8
8
*
1XX02
NOMESCO Finland
NA
40.3
6.8
8
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
40.3
6.8
8
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
40.3
6.8
8
*
A06AD11
ATC
lactulose; oral
1.8
6.7
111
642
I50.0
ICD-10 Finland
Congestive heart failure
2.3
6.7
57
252
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
6.7
168
1099
K02.9
ICD-10 Finland
Dental caries, unspecified
4.1
6.7
24
59
Z31.5
ICD-10 Finland
Genetic counselling
2.4
6.7
53
224
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.8
6.7
26
69
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
6.7
222
1556
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
22.7
6.7
9
*
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
22.7
6.7
9
*
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
22.7
6.7
9
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.4
6.7
30
90
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
6.6
75
375
ZY010
NOMESCO Finland
Hospital outpatient
2.3
6.6
59
267
H01AC01
ATC
somatropin; parenteral
7.9
6.6
14
18
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.1
6.6
24
60
N30.0
ICD-10 Finland
Acute cystitis
1.9
6.6
91
492
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.6
6.6
21
46
58099
ICD-8 Finland
Acute nephritis
12.3
6.6
11
9
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
12.3
6.6
11
9
K05.30
ICD-10 Finland
Periodontitis complex
1.8
6.6
109
630
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
8.8
6.6
13
15
E66.8
ICD-10 Finland
Other obesity
2.4
6.5
50
211
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
6.5
65
309
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
6.5
76
386
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
6.5
161
1051
H26.02
ICD-10 Finland
Presenil cataract
3.5
6.4
28
82
A05AA02
ATC
ursodeoxycholic acid; oral
4.3
6.4
22
52
A04AA01
ATC
ondansetron; systemic, rectal
2.3
6.4
57
256
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
70.2
6.4
7
*
K06.10
ICD-10 Finland
Gingival fibromatosis
70.2
6.4
7
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
14.4
6.4
10
7
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
14.4
6.4
10
7
M81.4
ICD-10 Finland
Drug-induced osteoporosis
14.4
6.4
10
7
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.9
6.4
19
39
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
6.3
75
383
I50.1
ICD-10 Finland
Left ventricular failure
2.7
6.3
41
156
E000001
ATC
NA
1.6
6.3
177
1191
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.9
6.3
89
486
H20.1
ICD-10 Finland
Chronic iridocyclitis
5.6
6.3
17
31
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.3
6.3
56
251
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.0
6.3
23
58
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
11.1
6.3
11
10
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
6.3
75
386
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
6.3
6
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
6.3
6
*
3XA02
NOMESCO Finland
NA
+∞
6.3
6
*
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
6.3
6
*
2798X
ICD-9 Finland
Disorders involving the immune mechanism, Other specified disorders involving the immune mechanism[MORBUS IMMUNOSYSTEMATIS ALIA DEFINITA]
+∞
6.3
6
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
6.3
6
*
132
Kela drug reimbursment
Sarcoidosis
+∞
6.3
6
*
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
6.3
6
*
N00.3
ICD-10 Finland
Acute nephritic syndrome, Diffuse mesangial proliferative glomerulonephritis
+∞
6.3
6
*
N06.3
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis
+∞
6.3
6
*
N0839, D8980
ICD-10 Finland
NA
+∞
6.3
6
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
6.2
68
337
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.8
6.2
19
40
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
26.8
6.2
8
*
TPX15
NOMESCO Finland
Removal of vascular injection port
7.1
6.2
14
20
H26.3
ICD-10 Finland
Drug-induced cataract
7.1
6.2
14
20
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
6.2
44
177
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
6.2
323
2489
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
6.3
6.2
15
24
SCD01
NOMESCO Finland
Simple removal of tooth plaque or tartar
6.3
6.2
15
24
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
6.1
252
1852
Z01.2
ICD-10 Finland
Dental examination
1.4
6.1
374
2970
N43.3
ICD-10 Finland
Hydrocele, unspecified
3.3
6.1
28
86
J01CF05
ATC
flucloxacillin; systemic
2.4
6.1
47
199
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
12.6
6.1
10
8
JN4BD
NOMESCO Finland
Extensive body CT
1.9
6.1
91
510
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.9
6.1
35
124
RJ420
NOMESCO Finland
NA
8.7
6.1
12
14
R05
ICD-10 Finland
Cough
1.6
6.0
155
1020
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
6.0
293
2227
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
587
601
19.12
307.65
11.4
4.8
ng/l
149.7
82.5
19.68
551
536
(3026250) Tacrolimus [Mass/volume] in Blood
200
56
43.12
307.65
33.9
36.0
ug/l
7.0
7.4
0.79
187
50
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
387
330
17.26
307.65
10.6
7.1
mg/l
1.8
1.4
7.07
376
311
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
295
210
18.62
307.65
10.3
7.0
iu/ml
3026.0
375.7
0.70
72
32
(40768446) Kidney Pathology biopsy report
267
42
82.77
307.65
1.7
2.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
670
835
18.10
307.65
22.2
9.1
mmol/l
13.0
9.0
26.97
658
796
(3003458) Phosphate [Moles/volume] in Serum or Plasma
766
1240
16.87
307.65
22.9
6.9
mmol/l
1.1
1.1
6.69
749
1162
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
270
159
21.96
307.65
5.4
4.3
u/ml
155.2
3151.1
—
9
13
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
538
1163
7.88
263.71
8.6
2.6
%
24.9
23.8
0.84
486
998
(3012516) Albumin [Mass/volume] in Urine
787
2473
8.09
263.52
9.6
3.3
mg/l
589.2
253.4
1.42
727
1655
(3042733) HLA Ab [Presence] in Serum
157
42
43.21
258.66
6.4
4.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
798
2609
7.90
253.81
11.6
4.0
mg/mmol
40.7
16.3
3.22
740
1719
(3004789) Transferrin [Mass/volume] in Serum or Plasma
546
1240
7.55
253.56
8.3
2.6
g/l
2.0
2.3
31.44
533
1153
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
251
225
14.03
248.05
2.6
1.5
u/ml
110.3
123.8
0.28
64
39
(3009508) Creatinine [Moles/volume] in Urine
813
2802
7.67
240.97
9.5
3.4
mmol/l
7.0
8.3
15.17
784
2366
(3010375) cycloSPORINE [Mass/volume] in Blood
155
51
35.03
240.68
27.1
34.7
ug/l
95.8
137.6
3.21
130
45
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
252
238
13.32
240.65
2.6
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
304
377
10.64
239.78
1.8
1.4
u/ml
42.6
9.3
—
10
11
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
251
240
13.14
237.67
2.6
1.5
u/ml
23.0
13.2
—
7
5
(3022948) Iron [Moles/volume] in Serum or Plasma
551
1335
7.07
237.32
8.3
2.6
umol/l
12.5
13.7
4.15
539
1242
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
849
3168
7.63
226.69
11.1
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
629
1820
6.50
221.36
7.1
2.6
e6/l
2.7
4.8
9.67
595
1595
(3024561) Albumin [Mass/volume] in Serum or Plasma
893
3591
7.93
216.34
17.0
5.4
g/l
34.6
36.0
13.15
872
3377
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
119
24
55.26
208.46
5.3
6.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
235
247
11.73
207.74
1.8
1.4
u/ml
242.0
250.6
0.13
180
143
(3002582) Erythrocytes [#/volume] in Urine
745
2657
6.23
202.54
9.6
3.3
e6/l
61.8
84.7
0.41
666
2047
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
234
257
11.21
200.26
1.7
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
693
2412
5.80
191.00
20.8
4.1
ph
7.4
7.4
5.11
150
476
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
269
376
9.06
190.74
2.7
2.1
g/l
1.4
1.4
0.16
240
327
(3026493) Urate [Moles/volume] in Serum or Plasma
682
2350
5.75
190.00
6.2
2.7
umol/l
866.9
5813.8
5.09
654
2078
(36304419) Bacteria [Presence] in Urine
686
2377
5.75
189.79
8.7
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
695
2437
5.76
189.49
9.2
3.2
e6/l
0.2
0.4
6.28
598
1835
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
166
117
16.44
187.15
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
168
123
15.85
185.47
2.2
2.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
232
279
10.19
185.13
2.0
1.5
g/l
0.3
0.2
1.57
217
266
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
234
291
9.87
181.85
2.0
1.5
g/l
1.2
1.2
0.08
221
278
(3018095) Leukocytes [#/volume] in Urine
780
3104
5.82
179.96
11.7
3.7
e6/l
22.4
76.8
2.60
683
2198
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
301
515
7.59
177.99
19.5
5.7
mmol/l
23.0
24.0
6.71
287
482
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
904
4154
6.74
173.24
33.6
7.6
mmol/l
1.2
1.2
2.13
802
3536
(3002032) Base excess in Venous blood by calculation
384
872
6.14
170.22
18.6
5.1
mmol/l
0.2
1.8
13.71
334
698
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
855
3790
6.06
169.65
27.9
7.0
mmol/l
1.2
1.2
5.85
831
3468
(3021447) Carbon dioxide [Partial pressure] in Venous blood
384
877
6.10
169.05
18.5
5.1
kpa
5.8
5.8
0.55
379
855
(3026782) Osmolality of Urine
550
1732
5.21
166.31
7.8
2.7
mosm/kgh2o
502.9
571.6
13.67
513
1480
(3048929) Epstein Barr virus Ab [Presence] in Serum
253
392
8.02
162.96
1.7
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
477
1359
5.32
162.30
4.2
2.6
s
29.5
29.9
0.94
469
1324
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
102
32
34.92
159.65
1.1
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
109
44
27.29
157.08
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
319
653
6.40
156.76
3.7
2.8
g/l
65.1
66.8
2.75
306
599
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
792
3449
5.27
156.01
4.3
2.3
nmol/l
74.1
74.5
0.17
777
3124
(3024471) HLA-A [Type]
109
45
26.68
155.79
1.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
102
35
31.92
155.28
1.1
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
385
954
5.59
153.26
6.0
4.7
u/l
240.6
245.5
0.28
371
904
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
133
94
15.89
149.03
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
160
157
11.70
146.74
8.9
3.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
734
3119
4.82
146.25
14.3
6.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
345
823
5.58
142.43
19.2
10.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
207
299
8.24
140.91
1.8
1.6
titre
156.3
200.0
—
8
8
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
471
1471
4.76
139.90
6.1
2.8
e6/l
0.5
1.0
3.19
312
838
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
77
13
63.46
138.75
12.5
4.3
mmol/l
5.5
7.1
1.18
77
13
(3017143) Hepatitis C virus Ab [Presence] in Serum
418
1200
4.93
137.88
3.8
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
117
80
16.19
133.21
1.2
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
456
1436
4.63
133.00
6.7
4.2
mmol/l
0.8
0.8
1.55
440
1358
(3004588) Protein electrophoresis panel - Serum or Plasma
256
517
6.10
125.78
2.7
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
100
56
19.48
125.63
5.7
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
355
969
4.87
123.14
6.7
3.2
%
1.9
1.8
1.05
338
881
(3024928) Oxygen saturation in Venous blood
155
187
9.44
121.77
14.5
5.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
299
716
5.31
121.29
5.4
3.2
e9/l
69.0
71.9
0.61
224
552
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
289
672
5.43
121.29
4.2
2.5
ml/min/173m2
43.1
70.2
18.82
140
263
(3034860) Kappa light chains.free [Mass/volume] in Serum
172
239
8.30
120.40
3.5
3.8
mg/l
73.8
80.6
0.09
131
188
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
172
239
8.30
120.40
3.5
3.8
mg/l
51.8
35.9
2.22
130
189
(3024354) Oxygen [Partial pressure] in Venous blood
303
743
5.20
119.39
15.1
4.5
kpa
6.4
4.8
10.07
296
724
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
170
237
8.26
118.62
3.5
3.7
ratio
2.0
1.8
0.10
14
26
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
98
60
17.78
117.87
5.7
2.1
%
12.1
11.6
0.10
74
33
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
83
35
25.50
117.26
3.1
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
428
1404
4.29
115.89
6.7
3.0
e6/l
1.3
1.7
0.43
265
774
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
445
1510
4.20
114.83
3.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
183
289
7.36
114.18
4.2
4.0
u/ml
0.3
0.4
1.38
86
156
(21494890) Protein electrophoresis panel - 24 hour Urine
107
82
14.30
114.06
2.1
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
125
128
10.85
110.65
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
100
77
14.14
106.20
15.6
8.1
%
11.3
10.8
0.44
100
77
(3011412) CD3 cells [#/volume] in Blood
103
85
13.23
104.94
5.5
2.1
e9/l
1.3
1.2
0.39
80
43
(3037121) Protein [Mass/volume] in Urine
187
335
6.48
102.99
6.1
4.7
g/l
0.7
0.3
1.59
149
173
(3009261) Glucose [Presence] in Urine by Test strip
805
4302
3.98
102.09
8.8
3.3
estimate
0.0
0.0
0.14
199
781
(3005719) IgG [Mass/volume] in Serum or Plasma
283
740
4.76
101.88
7.1
2.3
g/l
9.8
10.6
1.96
262
679
(3035350) Ketones [Presence] in Urine by Test strip
799
4269
3.93
100.88
8.9
3.3
estimate
0.0
0.0
0.00
198
803
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
122
138
9.78
100.27
1.2
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
832
4578
4.05
100.18
15.7
6.1
e9/l
0.6
0.6
5.07
767
3945
(3021601) Nitrite [Presence] in Urine by Test strip
796
4255
3.90
100.13
12.3
4.5
estimate
0.0
0.0
0.50
205
830
(3006315) Basophils [#/volume] in Blood
832
4591
4.03
99.44
15.7
6.2
e9/l
0.0
0.0
0.29
768
3965
(3022096) Basophils/100 leukocytes in Blood
785
4204
3.80
97.39
16.6
6.3
%
0.6
0.7
1.18
775
3952
(3019069) Monocytes/100 leukocytes in Blood
801
4352
3.84
97.03
16.9
6.6
%
8.8
8.7
0.83
788
4100
(3006504) Eosinophils/100 leukocytes in Blood
797
4331
3.81
96.18
16.6
6.3
%
2.9
2.9
0.01
788
4058
(3037467) Urinalysis macro (dipstick) panel - Urine
972
6053
5.17
95.96
12.4
4.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
182
340
6.18
95.80
2.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
838
4716
3.95
95.55
15.8
6.2
e9/l
1.8
2.0
1.97
772
4159
(3021879) Hepatitis B virus core Ab [Presence] in Serum
282
773
4.52
95.10
2.4
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
133
179
8.28
95.08
3.9
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
839
4748
3.93
94.31
17.2
6.5
e9/l
0.2
0.2
0.99
780
4174
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
86
63
14.69
93.81
5.9
2.3
e9/l
0.2
0.2
0.43
67
52
(46235355) HIV 1 and 2 tests - Meaningful Use set
473
1883
3.59
93.10
3.6
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
740
3890
3.58
92.87
8.2
2.8
ug/l
222.0
134.3
6.59
724
3622
(3002030) Lymphocytes/100 leukocytes in Blood
807
4488
3.75
92.38
16.6
6.3
%
25.9
28.5
9.51
794
4213
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
298
875
4.26
91.45
4.5
3.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
86
66
14.01
91.32
5.9
2.2
e6/l
596.1
553.4
0.19
67
53
(3018010) Neutrophils/100 leukocytes in Blood
795
4423
3.65
89.95
16.2
6.2
%
59.0
56.6
7.09
785
4174
(3023368) Bacteria identified in Blood by Culture
533
2326
3.43
89.93
9.1
4.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
117
144
8.94
89.90
1.8
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
371
1290
3.78
89.29
2.7
2.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
233
585
4.75
87.34
3.2
1.7
g/l
1.1
1.3
0.68
214
542
(3037522) Nuclear Ab [Titer] in Serum
354
1222
3.75
85.70
1.6
1.3
titre
618.8
446.2
0.57
64
234
(3032080) INR in Blood by Coagulation assay
666
3418
3.29
84.09
16.8
8.7
inr
1.2
1.2
0.02
204
1031
(3000060) B lymphocytes [#/volume] in Blood
61
28
22.96
83.06
7.0
1.8
e6/l
266.1
284.5
0.07
28
11
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
185
403
5.29
81.91
13.5
3.8
%
0.6
0.7
0.17
185
392
(3013650) Neutrophils [#/volume] in Blood by Automated count
865
5241
3.72
81.88
19.9
9.4
e9/l
4.5
4.1
4.65
804
4550
(3011397) Hemoglobin [Presence] in Urine by Test strip
461
1930
3.34
81.70
8.0
3.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
73
51
15.23
81.61
2.6
3.0
ml
1963.1
2017.7
0.12
67
46
(1616796) Gas panel - Central venous blood
128
198
7.16
80.64
8.1
3.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
898
5623
3.84
79.53
8.0
4.0
e6/l
39.9
242.6
1.30
14
80
(3033658) Prothrombin time (PT) actual/Normal
505
2289
3.17
77.36
10.5
4.2
%
97.6
90.0
7.64
496
2243
(3037756) Immunofixation for Serum or Plasma
115
167
7.55
76.64
1.7
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
107
144
8.10
76.17
3.1
1.8
g/l
1.0
0.9
0.13
74
114
(3015377) Calcium [Moles/volume] in Serum or Plasma
558
2728
3.05
73.99
6.8
3.3
mmol/l
2.3
2.4
3.73
531
2433
(4062490)
82
82
10.70
73.35
2.7
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
990
6777
4.56
73.05
18.0
7.6
u/l
80.5
79.9
0.18
978
6407
(3028192) IgG subclass 2 [Mass/volume] in Serum
81
81
10.69
72.44
2.5
1.3
g/l
2.7
2.9
0.35
52
58
(3027135) IgG subclass 1 [Mass/volume] in Serum
81
81
10.69
72.44
2.5
1.3
g/l
6.1
7.0
1.25
52
59
(3024139) IgG subclass 3 [Mass/volume] in Serum
81
81
10.69
72.44
2.5
1.3
g/l
0.4
0.4
0.06
51
58
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
122
205
6.55
70.84
1.8
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
283
946
3.65
70.49
2.5
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
284
952
3.64
70.44
2.6
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
141
275
5.71
70.24
1.9
2.5
g/l
10.2
10.5
0.25
122
241
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
298
5.52
70.20
2.1
2.5
g/l
7.4
7.2
0.69
115
235
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
298
5.52
70.20
2.1
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
298
5.52
70.20
2.1
2.5
g/l
4.4
3.9
2.82
112
224
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
352
1354
3.32
70.15
2.6
1.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
231
680
4.01
69.19
7.6
4.9
kpa
5.0
5.2
3.93
221
641
(3016750) Collection duration of Urine
70
61
12.16
68.57
3.7
2.4
min
506.4
500.2
0.18
62
43
(3009343) pH of Capillary blood
229
674
4.00
68.57
7.5
4.9
ph
7.4
7.4
0.67
51
76
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
224
650
4.05
68.41
7.4
5.0
mmol/l
0.5
1.7
4.64
164
477
(3014111) Lactate [Moles/volume] in Serum or Plasma
247
789
3.72
65.49
15.7
9.3
mmol/l
1.1
1.4
3.81
240
758
(3021589) Normoblasts [#/volume] in Blood
704
4100
2.88
64.53
26.9
9.6
e9/l
0.0
0.0
0.36
570
3328
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
137
281
5.41
64.43
2.1
2.6
g/l
3.1
3.1
0.09
113
227
(40758558) Short blood count panel - Blood
470
2252
2.85
62.15
15.0
6.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
152
352
4.83
61.99
2.2
1.2
u/l
36.2
37.4
0.28
139
310
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
120
227
5.79
61.57
2.4
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
120
228
5.77
61.28
2.2
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
743
4536
2.84
60.70
10.2
6.7
umol/l
10.2
12.1
4.25
721
4312
(3004775) Volume in Urine collected for unspecified duration
71
76
9.90
60.36
3.6
2.3
ml
820.0
638.6
2.01
63
48
(3015235) Bicarbonate [Moles/volume] in Capillary blood
122
242
5.53
59.42
5.1
3.3
mmol/l
22.9
24.7
3.94
114
217
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
202
607
3.83
58.16
2.1
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
290
1106
3.18
57.31
15.3
8.2
mmol/l
103.4
104.4
2.60
285
1082
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
118
237
5.44
56.63
2.4
2.7
g/l
0.0
0.0
0.05
109
221
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
124
264
5.15
55.70
2.4
2.8
g/l
0.5
1.3
1.87
112
240
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
89
141
6.76
54.46
2.2
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
281
1081
3.12
54.44
2.6
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
107
206
5.63
53.74
2.3
1.2
mg/l
14.6
10.9
2.62
99
186
(3017704) Immunofixation for Urine
53
45
12.30
52.63
1.2
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
110
223
5.35
52.17
2.0
2.7
g/l
0.0
0.0
0.50
101
207
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
432
2131
2.66
52.09
3.1
2.3
mg/l
3.1
2.9
0.62
397
1827
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
121
269
4.91
51.58
2.1
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
110
227
5.26
51.11
1.6
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
114
243
5.10
51.04
2.0
2.6
g/l
35.9
38.0
2.07
105
214
(3013826) Glucose [Moles/volume] in Serum or Plasma
787
5194
2.67
50.90
15.0
5.3
mmol/l
6.7
6.7
0.17
765
4866
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
108
222
5.27
50.40
2.0
2.7
g/l
0.0
0.0
0.00
101
207
(3036603) Volume of Urine
55
54
10.65
49.63
2.1
1.4
ml
1697.2
1806.5
—
14
10
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
59
65
9.52
49.01
3.1
2.8
%
42.4
43.4
0.10
37
17
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
42
27
16.11
48.79
3.3
1.8
u/ml
1058.0
1828.6
0.42
42
27
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
426
2147
2.57
48.46
4.4
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
102
207
5.31
48.25
4.3
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
90
165
5.84
47.52
2.2
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
101
206
5.28
47.50
8.3
4.2
mmol/l
2.0
2.6
1.36
70
136
(3028626) Oxygen [Partial pressure] in Capillary blood
125
308
4.44
46.82
5.3
5.5
kpa
9.3
8.8
2.07
119
289
(3044640) Blood type and Crossmatch panel - Blood
500
2768
2.44
45.85
4.9
2.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
90
171
5.63
45.73
4.8
2.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
73
113
6.83
45.57
2.3
1.9
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
62
81
8.04
44.97
1.3
1.2
titre
209.0
179.4
—
10
16
(3017181) Myelocytes/100 leukocytes in Blood
204
731
3.18
43.90
7.0
4.8
%
0.8
0.9
0.33
88
232
(4035726)
201
716
3.20
43.67
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
415
2157
2.46
43.23
3.5
2.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
115
283
4.41
43.07
1.9
1.5
iu/ml
1.2
0.0
0.81
27
56
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
104
238
4.71
42.65
4.6
2.5
ug/min
446.3
123.6
2.71
82
148
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
486
2739
2.35
41.84
4.3
2.7
u/l
63.3
56.5
2.50
477
2554
(3019309) Folate [Moles/volume] in Red Blood Cells
304
1384
2.63
41.75
2.0
1.7
nmol/l
1280.1
1166.1
1.11
264
1073
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
76
134
6.01
41.73
8.7
6.2
mg/l
11.9
10.6
1.44
69
127
(3002179) Metamyelocytes/100 leukocytes in Blood
188
662
3.20
41.53
6.4
4.6
%
0.5
0.5
0.04
70
167
(40761535) Cells panel - Urine sediment
188
674
3.14
40.22
10.1
3.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
367
1862
2.43
39.74
1.9
1.5
nmol/l
19.0
19.9
0.43
348
1593
(40767503) Oxygen content in Capillary blood by calculation
88
188
4.99
39.14
4.7
2.6
%
16.2
16.4
0.14
69
97
(3022493) Free Hemoglobin [Mass/volume] in Plasma
45
47
9.93
38.79
7.0
6.5
mg/l
111.3
85.9
0.34
40
40
(3036481) Cortisol [Moles/volume] in Serum or Plasma
215
848
2.89
38.75
2.6
2.1
nmol/l
338.3
361.7
1.07
198
796
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
122
339
3.91
38.71
6.7
3.3
%
96.1
90.4
1.66
116
323
(3006184) Hemoglobin [Mass/volume] in Capillary blood
88
190
4.94
38.65
3.8
2.3
g/l
123.5
132.0
2.12
76
138
(3005322) IgE [Units/volume] in Serum or Plasma
170
594
3.19
37.88
2.3
1.3
u/ml
521.3
247.1
0.67
152
552
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
105
268
4.21
37.39
3.2
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
178
647
3.08
37.03
7.5
5.0
%
0.0
0.2
1.73
73
180
(3007164) IgA [Mass/volume] in Serum or Plasma
366
1915
2.34
36.44
2.6
1.4
g/l
3.0
2.4
3.42
281
1203
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
30
18
17.09
35.92
2.4
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
876
6568
2.45
35.65
7.8
3.9
mm/h
20.4
10.8
35.38
844
6114
(3052851) Hemolysis interference index of Serum or Plasma
98
248
4.23
35.27
4.7
3.4
—
—
—
0
0
(44790047)
65
116
5.88
35.20
2.6
1.7
—
—
—
0
0
(44806118)
65
116
5.88
35.20
2.6
1.7
—
—
—
0
0
(44790048)
65
116
5.88
35.20
2.6
1.7
—
—
—
0
0
(44790049)
65
116
5.88
35.20
2.6
1.7
—
—
—
0
0
(3036489) Thrombin time
125
378
3.59
34.97
6.4
2.8
s
22.9
21.7
0.96
117
339
(3029937) Albumin [Presence] in Urine by Test strip
407
2261
2.25
34.85
10.1
3.5
estimate
0.0
0.0
0.89
161
797
(3021440) Promyelocytes/100 leukocytes in Blood
181
690
2.93
34.48
7.5
4.9
%
0.1
0.1
0.40
83
214
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
145
489
3.25
34.13
11.5
13.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
51
73
7.27
34.12
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
149
516
3.17
33.54
8.0
5.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
206
859
2.71
33.04
3.3
2.6
u/l
37.5
95.3
0.53
193
743
(3002173) Hemoglobin [Mass/volume] in Arterial blood
201
829
2.73
32.93
11.1
9.9
g/l
112.0
123.1
9.72
195
799
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
225
982
2.61
32.92
10.5
9.2
kpa
5.0
5.1
1.79
216
943
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
158
4.94
32.88
1.6
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
101
275
3.93
32.87
2.3
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
225
983
2.61
32.85
10.5
9.2
kpa
11.6
12.4
1.33
216
948
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
173
661
2.91
32.73
15.3
3.9
mmol/l
1.2
1.2
0.39
168
576
(3025315) Body weight
39
8
50.38
32.69
5.0
3.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
210
889
2.67
32.66
10.7
9.7
%
94.7
95.7
1.42
202
859
(3003396) Base excess in Arterial blood by calculation
224
981
2.60
32.51
10.3
9.2
mmol/l
-0.2
1.1
4.16
180
779
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
530
3334
2.10
32.44
9.5
3.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
50
77
6.75
31.28
1.9
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
112
339
3.56
31.21
2.8
2.0
ug/l
2.0
2.5
0.14
104
305
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
70
155
4.75
29.77
1.3
1.2
u/ml
6.6
1.0
—
7
8
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
141
507
3.03
29.63
1.9
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
75
6.64
29.62
5.6
2.2
e6/l
785.6
800.6
—
7
30
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
10
22.41
29.61
8.9
5.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
210
935
2.53
29.22
2.4
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
412
2433
2.09
29.09
8.0
2.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
37
44
8.66
28.87
1.1
1.0
miu/ml
1502.4
1480.7
0.04
37
44
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
606
4124
2.01
28.67
6.9
4.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
511
3289
2.01
28.20
2.4
1.9
pmol/l
100.5
95.0
1.59
289
1813
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
52
94
5.75
27.75
2.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
56
109
5.35
27.61
1.9
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
486
3100
1.99
27.27
5.5
3.5
u/l
30.1
33.4
1.97
465
2960
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
52
96
5.63
27.15
1.9
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
35
42
8.57
27.11
1.5
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
37
48
7.93
26.90
1.5
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
357
2062
2.07
26.26
9.9
4.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
176
757
2.57
26.16
12.5
3.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
417
2556
2.00
25.92
2.5
2.2
u/l
152.4
269.9
2.22
398
2419
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
41
63
6.71
25.68
7.4
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
41
63
6.71
25.68
7.5
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
395
2387
2.00
25.48
2.2
1.7
mmol/l
1.6
1.4
2.17
372
2019
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
56
119
4.90
24.99
1.7
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
106
359
3.15
24.58
2.3
2.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
43
74
6.00
24.13
1.7
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
68
175
4.07
23.85
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
68
175
4.07
23.85
1.7
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1067
9307
3.38
23.73
53.6
15.2
mmol/l
139.4
139.7
3.18
1057
9081
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
75
208
3.79
23.71
1.3
1.2
u/ml
6.8
3.0
—
7
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
67
173
4.05
23.39
1.5
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
75
210
3.75
23.38
1.3
1.2
u/ml
4.7
16.0
—
9
31
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
123
467
2.83
23.27
11.1
12.1
mmol/l
23.0
24.5
5.71
118
447
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
123
468
2.83
23.18
9.0
5.5
mmol/l
23.6
24.6
5.12
114
450
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
77
221
3.66
23.16
1.3
1.2
u/ml
29.1
22.6
—
6
8
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
983
8261
2.40
23.12
9.6
5.4
mmol/mol
38.9
39.6
1.85
958
7730
(3001964) Herpes simplex virus Ag [Presence] in Specimen
23
19
12.33
23.01
2.7
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1067
9340
3.31
22.90
55.9
15.3
mmol/l
4.1
4.0
35.68
1057
9099
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
58
139
4.34
22.34
1.7
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
45
88
5.28
22.07
1.2
1.2
u/l
59.7
61.0
0.05
36
62
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
129
4.43
21.77
1.4
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1057
9259
3.01
21.57
44.5
13.2
mg/l
19.9
24.0
5.63
968
7189
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
124
494
2.69
21.36
1.9
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
64
171
3.91
21.32
1.4
1.2
u/ml
36.0
37.0
—
8
12
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
25
5
51.04
21.18
1.9
1.0
mg/l
3.6
—
—
10
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
36
60
6.16
20.85
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
36
60
6.16
20.85
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
36
60
6.16
20.85
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
410
2645
1.86
20.84
1.8
1.5
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
26
7
37.97
20.83
4.0
3.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
17
10
17.24
20.32
1.4
1.6
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
62
5.96
20.18
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
62
5.96
20.18
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
62
5.96
20.18
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
52
125
4.31
19.95
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
65
184
3.69
19.94
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
37
67
5.67
19.70
5.5
4.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
97
357
2.88
19.38
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
49
116
4.37
19.17
2.5
2.4
pg
31.9
33.1
1.07
49
116
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
48
113
4.39
18.92
1.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
58
158
3.81
18.81
1.4
1.2
u/ml
3.7
6.8
0.68
26
71
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
177
882
2.19
18.50
2.8
2.7
g/l
0.2
0.2
0.04
170
827
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
19
10.70
18.26
1.6
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
23
27
8.67
18.06
2.6
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
22
9.71
17.93
2.8
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
39
81
4.95
17.88
1.3
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
17
13
13.26
17.70
3.0
4.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
318
1979
1.84
17.60
4.2
2.0
mg/l
1.5
1.1
1.62
266
1494
(3042111) Morphology [Interpretation] in Bone marrow Narrative
53
142
3.87
17.59
3.1
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
60
177
3.52
17.32
1.6
1.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
21
6
35.62
16.70
2.5
4.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
39
86
4.66
16.67
5.3
4.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
33
7.41
16.57
1.5
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
17
10.74
16.46
1.6
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
77
275
2.93
16.24
1.4
1.2
titre
46.4
103.6
1.95
11
22
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
977
8496
2.07
16.23
37.8
12.0
ml/min/173m2
59.3
85.4
96.67
904
6996
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
39
88
4.55
16.21
2.2
2.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
38
84
4.65
16.19
1.2
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
921
7858
1.91
16.07
55.9
16.2
%
14.0
13.6
12.66
914
7713
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
992
8685
2.12
16.01
6.5
3.8
mmol/l
1.5
1.3
8.64
963
8076
(3008536) Aspergillus sp Ab [Presence] in Serum
20
23
8.83
15.93
4.1
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
40
94
4.37
15.81
1.4
1.4
g/l
27.5
31.8
1.08
35
80
(3019060) Gas panel - Arterial blood
121
549
2.35
15.73
7.6
5.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
264
1603
1.84
15.56
5.5
3.5
ng/l
177.6
549.6
2.82
209
1195
(3044889) 12 lead EKG panel
763
6189
1.71
15.51
4.8
3.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
53
156
3.51
15.36
1.4
1.2
u/ml
3.6
3.7
0.01
13
49
(3008152) Bicarbonate [Moles/volume] in Arterial blood
116
523
2.36
15.30
9.6
8.0
mmol/l
23.4
24.4
1.59
110
489
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
337
2215
1.74
15.14
4.3
3.2
ng/l
4615.3
1278.5
6.58
299
1861
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
25
8.13
14.92
1.7
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
58
5.29
14.91
1.5
1.9
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
92
378
2.56
14.82
8.6
4.2
%
60.3
50.9
2.79
92
373
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1012
8987
2.15
14.77
7.0
4.1
mmol/l
1.3
1.4
8.63
982
8367
(3004809) Band form neutrophils/100 leukocytes in Blood
49
142
3.56
14.55
4.0
3.6
%
0.5
1.4
1.88
44
118
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
192
1073
1.95
14.53
7.1
3.1
umol/l
7.4
8.9
0.55
171
946
(3003181) Sodium [Moles/volume] in Urine
46
129
3.67
14.33
2.3
1.6
mmol/l
61.0
61.1
0.01
41
111
(3009871) Measles virus Ab [Titer] in Serum
23
36
6.50
14.14
1.9
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1023
9161
2.16
13.98
7.3
4.6
mmol/l
2.6
2.8
13.95
994
8527
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
29
58
5.10
13.89
1.3
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
8
24.12
13.81
2.6
1.6
ng/l
211.6
103.0
—
19
8
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1013
9047
2.10
13.80
7.2
4.2
mmol/l
4.4
4.6
11.33
986
8475
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
127
623
2.17
13.66
3.8
2.9
ng/l
379.8
173.1
2.36
114
560
(3023419) Bacteria identified in Sputum by Culture
42
116
3.72
13.39
3.0
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
84
347
2.53
13.38
3.0
1.6
u/l
9.8
8.0
0.59
64
280
(3045142) Bone marrow Pathology biopsy report
41
115
3.66
12.79
1.6
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
83
349
2.49
12.74
3.3
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
32
75
4.36
12.71
1.4
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
21
35
6.09
12.15
1.1
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1068
9829
2.43
12.03
27.0
9.9
u/l
26.0
28.7
7.44
1057
9530
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
54
4.90
11.94
1.3
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
284
1887
1.67
11.82
9.5
3.5
kg/l
1.0
1.0
0.22
38
262
(3000494) Fungus identified in Specimen by Culture
186
1096
1.83
11.81
2.1
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
51
4.99
11.72
1.6
2.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
51
4.99
11.72
1.6
2.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
15
5
30.37
11.66
3.6
3.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
41
5.45
11.38
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
29
69
4.29
11.32
1.5
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
450
3372
1.55
11.25
2.3
2.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
15
6
25.30
11.15
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
224
1418
1.72
11.09
3.4
3.0
mmol/l
2.5
2.4
1.40
204
1249
(3020393) Adenovirus Ag [Presence] in Stool
17
25
6.89
11.04
2.4
2.0
—
—
—
0
0
(3019225) pH of Specimen
138
754
1.94
11.03
15.7
4.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
66
268
2.55
10.92
1.2
1.1
—
—
—
0
0
(4268621)
37
108
3.51
10.91
2.2
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
61
240
2.63
10.76
1.9
1.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
16
9
18.01
10.74
6.4
6.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
9
18.01
10.74
6.4
6.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
66
271
2.52
10.67
1.3
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
433
3247
1.54
10.64
4.4
3.4
ng/l
75.7
46.3
0.76
338
2137
(3023199) Leukocytes [#/volume] in Pleural fluid
31
82
3.86
10.53
1.5
1.3
e6/l
1387.3
2291.7
0.82
24
50
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
12
10.10
10.45
2.1
2.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
66
274
2.50
10.43
11.0
8.0
mmol/l
1.5
1.3
0.39
59
235
(3000570) Elastase.pancreatic [Mass/mass] in Stool
64
262
2.53
10.42
1.5
1.5
ug/g
273.3
286.4
0.21
46
157
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
14
6
23.60
10.25
5.8
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
113
3.35
10.19
8.8
3.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
52
196
2.73
9.98
12.4
9.4
mmol/l
104.5
105.7
0.96
45
178
(3039000) Anion gap in Blood
52
196
2.73
9.98
12.4
9.4
mmol/l
13.0
11.4
1.62
45
178
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
228
1490
1.66
9.93
1.5
1.3
iu/ml
52.5
33.3
0.73
79
457
(3032352) Blasts [#/volume] in Cerebral spinal fluid
12
13
9.32
9.88
17.8
4.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
23
51
4.58
9.80
1.4
1.4
u/ml
23.6
21.6
—
5
9
(3045424) Erythrocytes [Presence] in Urine
44
153
2.95
9.79
1.6
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
189
1179
1.72
9.78
2.6
2.6
ug/g
116.2
123.6
0.14
160
961
(3042631) Mycobacterium sp identified in Specimen
35
106
3.37
9.77
2.3
3.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
16
8.21
9.75
2.0
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
29
5.94
9.61
1.1
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
20
41
4.95
9.33
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
751
6424
1.50
9.19
5.7
3.2
u/l
55.4
49.3
1.20
722
6062
(3023183) Ammonium ion [Moles/volume] in Plasma
55
229
2.47
8.67
4.9
3.6
umol/l
29.5
36.0
1.86
47
195
(3020891) Body temperature
71
331
2.22
8.67
7.5
4.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
29
5.58
8.51
1.0
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
6
20.19
8.48
1.6
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
73
348
2.17
8.45
10.5
6.8
%
0.9
0.9
0.04
67
326
(3021788) Differential panel - Synovial fluid
42
156
2.76
8.32
2.0
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
123
709
1.82
8.31
2.3
2.4
ug/l
6.7
8.0
0.24
107
647
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
24
63
3.87
8.27
1.5
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
246
1708
1.56
8.21
1.7
1.6
pmol/l
29825031.2
42640365.4
0.15
228
1447
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
20
46
4.41
8.17
1.3
1.1
—
12.5
—
0
6
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
773
6723
1.47
8.12
4.4
3.6
pmol/l
14.7
14.7
0.01
733
6150
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
73
354
2.14
8.10
10.5
6.7
%
1.7
1.6
0.58
67
331
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
55
4.06
8.09
2.9
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
74
3.57
8.00
1.3
1.3
e6/l
26195.7
27953.8
0.05
18
36
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
14
7.92
8.00
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
179
1162
1.64
7.89
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
909
8194
1.55
7.81
5.2
4.3
mu/l
1.9
2.2
0.56
874
7554
(40761511) CBC panel - Blood by Automated count
1042
9725
1.86
7.75
38.4
12.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
53
4.02
7.63
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
69
336
2.12
7.59
1.8
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
59
273
2.22
7.37
1.5
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
746
6499
1.43
7.35
3.5
3.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
46
4.18
7.29
2.6
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
19
6.37
7.25
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
30
100
3.05
7.23
1.3
1.4
pmol/l
374.4
446.5
0.22
22
83
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
30
5.05
7.19
1.4
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
15
30
5.05
7.19
1.1
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
52
3.90
7.00
1.4
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
52
3.90
7.00
1.2
1.1
ratio
1.1
1.1
—
9
20
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
15
31
4.89
6.94
6.6
7.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
65
323
2.07
6.80
1.2
1.3
miu/ml
119.8
221.6
1.81
16
152
(3045788) Cell count panel - Pleural fluid
22
63
3.54
6.73
1.3
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
48
212
2.32
6.71
2.4
1.6
e6/l
14204.9
12532.9
0.16
33
160
(3009542) Hematocrit [Volume Fraction] of Blood
953
8761
1.54
6.66
47.3
14.1
%
37.7
40.7
26.09
722
6726
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
204
1420
1.53
6.63
1.4
1.2
u/ml
11.2
11.7
0.04
56
571
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
100
2.95
6.62
2.1
1.5
%
52.3
60.6
0.37
16
72
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
30
107
2.85
6.45
1.6
1.2
ug/l
4.9
2.7
0.34
25
92
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
75
3.25
6.44
2.0
1.4
%
16.0
29.1
1.49
14
55
(3023323) Follitropin [Units/volume] in Serum or Plasma
75
402
1.93
6.37
3.1
1.5
iu/l
17.6
22.2
0.79
60
329
(4306422)
38
155
2.50
6.32
1.1
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
30
4.71
6.22
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
88
501
1.82
6.21
1.4
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
280
2107
1.44
6.12
1.3
1.3
u/ml
3.6
1.7
0.67
73
570
(3022217) INR in Platelet poor plasma by Coagulation assay
149
983
1.59
6.11
35.0
21.6
inr
1.3
1.3
0.09
20
139
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
94
2.92
6.07
1.4
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
24
79
3.08
5.94
1.3
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
18
49
3.72
5.93
1.4
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
26
90
2.93
5.91
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
36
4.21
5.83
1.2
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
36
4.21
5.83
1.2
2.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
9
11.20
5.80
1.4
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
156
2.42
5.76
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
40
175
2.33
5.75
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
195
2.25
5.69
1.7
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
159
1085
1.54
5.63
1.4
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
42
3.85
5.55
1.2
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
42
3.85
5.55
1.2
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
42
3.85
5.55
1.2
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
42
3.85
5.55
1.2
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
22
73
3.05
5.39
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
43
3.76
5.38
1.6
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
43
3.76
5.38
1.6
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
30
4.37
5.30
6.9
7.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
8
11.33
5.29
1.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
74
3.01
5.27
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
74
3.01
5.27
1.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
74
3.01
5.27
1.2
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
85
2.86
5.27
3.8
4.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
22
5.04
5.27
1.4
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
22
5.04
5.27
1.4
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
12
26
4.65
5.26
6.1
1.7
—
—
—
0
0
(3013512) EKG study
305
2385
1.38
5.25
4.4
3.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
54
3.37
5.18
1.4
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
245
1852
1.41
5.14
1.7
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
92
2.76
5.13
1.4
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
40
3.79
5.10
1.1
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
31
4.23
5.10
3.6
5.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
939
8729
1.43
5.02
6.7
4.2
mmol/l
6.0
5.9
0.26
907
8030
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
71
2.99
5.00
2.5
1.4
u/ml
0.9
0.3
0.31
13
34
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
68
385
1.81
4.93
2.4
2.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
31
130
2.42
4.92
1.6
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
56
992
0.54
4.87
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
163
2.25
4.82
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
37
3.82
4.82
1.2
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
42
3.61
4.77
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
677
0.46
4.76
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
47
3.44
4.76
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
83
506
1.69
4.67
5.8
2.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
38
3.72
4.65
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
38
3.72
4.65
1.3
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
98
2.59
4.57
1.1
1.3
nmol/l
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
21
4.80
4.53
1.2
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
12
30
4.03
4.44
1.7
1.9
ug/l
71.3
83.3
0.16
12
30
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
13
35
3.75
4.37
1.4
1.1
g/l
0.3
0.3
—
6
28
(3023410) Appearance of Cerebral spinal fluid
26
107
2.46
4.32
12.5
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
145
1027
1.47
4.29
1.5
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
9
8.94
4.28
1.3
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
6
11.73
4.28
5.3
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
6
11.73
4.28
1.0
1.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
17
56
3.07
4.25
1.2
1.1
—
43.2
—
0
5
(3016018) Differential panel - Cerebral spinal fluid
25
102
2.48
4.23
8.0
1.9
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
62
2.93
4.18
1.8
1.5
u/l
3.9
4.3
—
9
29
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
27
115
2.38
4.18
1.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
70
1115
0.60
4.11
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
136
2.24
4.05
1.5
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
9
14
6.47
3.98
1.4
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
11
28
3.96
3.98
6.0
1.9
e6/l
1664.0
2812.9
—
5
17
(3017354) Segmented neutrophils/100 leukocytes in Blood
22
87
2.56
3.98
2.4
3.5
%
65.4
54.8
1.38
16
62
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
33
3.66
3.93
1.5
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
24
4.19
3.89
1.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
493
1.63
3.86
3.8
3.6
pmol/l
4.4
4.7
0.79
66
436
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
89
581
1.58
3.86
1.3
1.3
au/ml
28.2
44.8
—
5
28
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
207
1.97
3.86
9.1
1.6
e6/l
20.8
24.1
0.05
30
167
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
40
207
1.97
3.86
9.1
1.7
e6/l
224.2
1336.9
0.68
30
173
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
5
12.05
3.76
1.5
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
39
202
1.96
3.76
8.8
1.6
mmol/l
3.5
3.7
0.50
34
191
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
84
2.53
3.73
1.9
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
137
987
1.44
3.72
1.4
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
25
4.03
3.70
1.4
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
25
4.03
3.70
1.4
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
37
192
1.96
3.56
9.8
1.7
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
6
10.04
3.50
1.2
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
6
6
10.04
3.50
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
48
274
1.78
3.46
1.3
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
13
42
3.12
3.37
1.6
2.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
53
2.85
3.36
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
48
277
1.77
3.35
1.3
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
48
2.94
3.30
8.0
3.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
7
8.61
3.26
1.5
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
272
1.76
3.26
1.3
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1079
10461
1.62
3.21
62.9
19.2
e9/l
245.2
248.5
0.90
1069
10204
(3024263) Appearance of Synovial fluid
13
44
2.98
3.14
2.8
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
73
2.49
3.14
1.2
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
1079
10467
1.60
3.13
62.5
19.1
fl
91.3
90.5
5.76
1073
10337
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
105
2.22
3.10
1.1
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
1079
10469
1.60
3.10
62.5
19.1
pg
30.2
30.3
0.48
1073
10338
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
39
3.10
3.09
1.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
39
3.10
3.09
1.6
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1079
10470
1.60
3.08
62.8
19.2
e12/l
4.3
4.6
42.43
1067
10191
(3010813) Leukocytes [#/volume] in Blood
1079
10472
1.60
3.05
63.0
19.2
e9/l
7.6
6.7
1.12
1068
10192
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
74
2.46
3.05
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
16
5.03
3.05
2.6
1.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
29
3.47
3.05
6.2
2.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1079
10474
1.59
3.03
63.2
19.3
g/l
128.1
138.3
65.26
1073
10341
(3048879) Bone marrow aspiration report
9
21
4.31
2.99
1.0
2.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
129
2.04
2.87
3.9
2.9
nmol/l
0.8
0.9
0.74
16
102
(3014051) Protein [Presence] in Urine by Test strip
31
164
1.92
2.87
6.0
1.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
13
5.41
2.87
1.4
2.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
9
6.69
2.87
2.0
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
29
150
1.96
2.86
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
87
606
1.47
2.85
3.1
2.8
e9/l
4.7
4.1
1.06
74
499
(3008295) Osmolality of Serum or Plasma
22
103
2.16
2.82
1.9
1.5
mosm/kgh2o
280.2
285.9
0.74
17
80
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
103
2.16
2.82
1.6
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
18
4.47
2.80
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
23
3.94
2.77
1.6
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
23
3.94
2.77
1.6
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
6
8.36
2.75
1.2
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
267
0.37
2.72
1.2
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
145
1115
1.34
2.71
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
105
2.12
2.70
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
22
105
2.12
2.70
1.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
128
966
1.37
2.70
3.1
2.3
nmol/l
12.7
13.4
0.52
117
867
(40768441) Liver Pathology biopsy report
17
73
2.35
2.66
1.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
22
106
2.10
2.64
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
106
2.10
2.64
1.6
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
156
1.88
2.58
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
11
5.48
2.54
1.0
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
11
5.48
2.54
1.2
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
11
5.48
2.54
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
333
1.59
2.53
2.3
1.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
16
4.40
2.47
1.4
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
152
1.86
2.44
1.1
1.0
u/ml
2.7
1.8
—
6
62
(40765096) Chromosome analysis panel by Banding
10
34
2.96
2.41
1.5
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
8
6.27
2.37
2.4
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
22
3.65
2.36
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
22
3.65
2.36
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
22
3.65
2.36
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
22
3.65
2.36
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
106
2.00
2.26
1.7
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
18
3.91
2.25
1.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
422
3757
1.20
2.21
3.9
4.5
ug/l
2.2
2.3
0.15
393
3388
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
50
330
1.54
2.17
1.8
2.4
u/l
2612.1
3690.4
0.16
18
127
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
19
94
2.04
2.16
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
19
3.70
2.15
1.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
7
19
3.70
2.15
3.0
1.5
—
—
—
0
0
(4027681)
14
61
2.31
2.15
1.4
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
37
2.72
2.10
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
25
3.22
2.09
2.9
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
20
3.51
2.05
2.4
1.2
—
—
—
0
0
(4024509)
13
56
2.34
2.05
4.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
55
377
1.48
2.02
10.8
3.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
17
83
2.06
2.01
1.2
1.2
nmol/l
1.3
1.4
0.24
17
77
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
32
2.83
2.00
1.3
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
21
3.35
1.96
1.1
3.7
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
21
3.35
1.96
1.3
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
64
2.20
1.95
1.1
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
45
2.46
1.93
2.7
3.7
ug/l
1.4
1.7
0.16
11
40
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
39
2.58
1.92
1.1
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
52
0.00
1.88
0.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
7
22
3.19
1.88
1.4
3.2
—
33.3
—
0
8
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
22
3.19
1.88
7.0
8.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
136
1094
1.28
1.87
1.5
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
53
0.00
1.87
0.0
3.5
—
73.2
—
0
53
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
12
4.18
1.82
1.6
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.4
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
12
4.18
1.82
1.6
1.0
—
—
—
0
0
(44806071)
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
69
507
1.38
1.78
1.4
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
60
2.18
1.78
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
60
2.18
1.78
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
47
322
1.48
1.76
1.5
1.7
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
12
54
2.24
1.74
1.8
2.3
ug/min
424.2
177.4
—
5
9
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
103
1.86
1.72
1.4
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
13
3.86
1.71
1.4
3.0
mmol/l
19.9
25.3
—
5
13
(3008898) HLA-B27 [Presence]
54
383
1.43
1.71
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
45
309
1.48
1.68
2.0
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
29
180
1.63
1.67
1.8
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
19
3.17
1.66
1.5
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
14
3.58
1.61
1.0
1.3
umol/24h
1.1
2.1
—
5
14
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
91
1.88
1.61
1.2
1.0
—
—
—
0
0
(4094501)
36
239
1.52
1.59
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
94
739
1.30
1.57
1.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
92
1.86
1.56
1.1
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
15
3.34
1.52
1.4
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
21
2.87
1.50
1.3
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
45
2.23
1.46
1.5
3.6
—
—
—
0
0
(4010399)
79
614
1.31
1.45
1.6
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
15
81
1.86
1.40
4.5
4.7
u/ml
29.0
50.0
—
6
26
(1761868) Lipid panel - Serum or Plasma
324
3581
0.87
1.39
3.7
2.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
67
1.95
1.38
1.2
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
17
2.95
1.36
1.6
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
196
0.51
1.35
1.7
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
192
0.52
1.28
1.7
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
516
0.71
1.27
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
33
227
1.47
1.27
1.6
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
99
1.73
1.27
1.3
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
191
0.52
1.26
1.7
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
(4015189)
5
19
2.64
1.21
1.2
2.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
26
2.31
1.19
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
117
981
1.21
1.18
17.8
6.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
30
2.34
1.12
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
30
2.34
1.12
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
23
151
1.53
1.12
2.1
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
31
2.27
1.10
1.4
2.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
185
1.47
1.09
2.2
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
38
511
0.73
1.08
1.4
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
105
1.63
1.06
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
34
247
1.39
1.02
2.6
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
50
1.81
0.96
1.9
1.3
nmol/l
139.8
151.8
—
9
50
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
234
0.64
0.95
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
234
0.64
0.95
1.6
1.4
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
37
1.90
0.94
1.1
1.3
nmol/l
82.7
125.7
—
7
27
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
233
0.64
0.94
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
233
0.64
0.94
1.6
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
28
2.15
0.91
1.5
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
28
2.15
0.91
1.5
3.0
—
—
—
0
0
(3000492) Spirometry study
112
965
1.18
0.88
1.5
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
72
1.67
0.85
1.2
1.4
umol/l
13.3
13.7
0.06
12
66
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
72
1.67
0.85
1.8
1.6
g/l
0.9
1.0
0.61
12
72
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
248
0.68
0.81
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
271
0.70
0.81
1.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
94
806
1.18
0.80
3.1
4.5
ug/l
37.8
27.9
0.14
77
669
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
82
1.59
0.78
1.4
1.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.3
—
26.2
—
0
23
(3011288) Drugs identified in Urine by Screen method
27
357
0.75
0.74
1.7
3.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
228
1.32
0.73
1.2
1.1
u/ml
4.0
2.7
0.15
16
105
(3015183) Erythrocyte sedimentation rate
10
60
1.67
0.72
1.3
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
11
68
1.62
0.72
1.2
1.1
u/ml
0.5
0.6
—
5
27
(3014271) Vancomycin [Susceptibility]
7
43
1.63
0.67
3.7
2.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
11
166
0.66
0.64
4.6
5.5
umol/l
311.8
365.1
0.79
11
149
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
18
130
1.39
0.61
1.4
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
50
1.60
0.61
2.3
2.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
51
1.57
0.60
2.1
3.3
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
1.9
—
0
15
(44813793)
10
64
1.57
0.58
1.2
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
86
0.58
0.56
1.4
1.1
—
—
—
0
0
(4211845)
6
37
1.62
0.55
1.7
3.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
40
481
0.83
0.54
1.5
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
43
513
0.83
0.54
1.5
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
74
1.49
0.53
1.5
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
43
511
0.84
0.52
1.5
2.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
83
1.45
0.52
1.1
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
40
1.50
0.51
1.2
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
109
1.38
0.51
3.7
2.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
43
507
0.84
0.49
1.5
2.5
—
—
—
0
0
(4034850)
33
271
1.22
0.49
15.6
9.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
208
1.26
0.48
1.0
1.1
u/ml
5.0
7.6
0.37
16
118
(3027944) Amphetamines [Presence] in Urine
43
505
0.85
0.47
1.5
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
220
0.77
0.45
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
193
1.25
0.43
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
48
553
0.86
0.43
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
119
1294
0.91
0.42
1.8
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
70
1.43
0.41
1.3
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
34
1.47
0.40
1.8
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
34
1.47
0.40
1.4
3.2
—
—
—
0
0
(4281824)
8
60
1.34
0.40
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
68
607
1.13
0.40
1.3
1.2
iu/ml
101.0
158.0
0.69
21
242
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
112
1030
1.10
0.39
5.8
4.2
%
31.0
31.2
0.07
97
716
(3035320) C reactive protein [Mass/volume] in Body fluid
9
66
1.37
0.38
3.0
1.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
235
0.81
0.37
1.9
3.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
42
1.43
0.35
4.0
5.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
42
1.43
0.35
2.0
2.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
13
99
1.32
0.35
4.1
2.2
mg/l
23.0
20.4
—
8
26
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
44
1.37
0.34
1.7
2.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
44
1.37
0.34
1.3
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19
154
1.24
0.34
3.1
3.2
u/ml
39.7
31.8
0.07
19
146
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
118
1.27
0.33
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
201
1.20
0.32
1.0
1.1
u/ml
0.5
1.3
0.70
14
99
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
34
391
0.87
0.32
2.0
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
311
2994
1.05
0.32
3.4
4.0
%
27.8
21.1
7.34
137
1314
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
1181
0.92
0.32
1.7
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
84
1.31
0.30
1.6
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
57
1.23
0.29
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
36
407
0.88
0.28
1.5
2.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
63
1.27
0.27
2.1
1.6
—
—
—
0
0
(4146454)
11
87
1.27
0.24
3.0
2.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
133
1394
0.95
0.21
1.7
1.9
%
1.8
1.5
2.54
117
1237
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.7
—
72.4
—
0
11
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
22
192
1.15
0.21
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
22
193
1.14
0.19
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
66
0.76
0.17
1.2
1.1
nmol/l
373.0
401.7
—
5
57
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
119
0.84
0.15
1.1
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
22
242
0.91
0.13
1.5
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
95
1.16
0.11
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
43
407
1.06
0.10
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
216
2198
0.98
0.09
2.6
2.9
ug/l
0.9
0.7
1.90
157
1355
(4198724)
6
56
1.07
0.08
1.5
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
215
1.07
0.07
1.4
1.9
iu/l
9.8
5.2
—
6
73
(3023511) Choriogonadotropin [Units/volume] in Urine
19
176
1.08
0.07
1.3
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
85
1.06
0.07
1.1
1.9
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
89
1.12
0.07
1.2
1.0
mg/l
257.3
274.9
—
10
80
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
52
502
1.04
0.06
1.5
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
61
627
0.97
0.05
1.9
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
141
0.92
0.05
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
48
467
1.03
0.04
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
151
1.06
0.03
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
202
1.04
0.02
7.1
4.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
232
0.99
0.00
1.6
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
153
0.98
0.00
1.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
35.4
—
0
9
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.7
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
168.0
—
0
8
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
7
72
0.97
0.00
1.1
1.1
—
4.1
—
0
10
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
10.8
7.1
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.3
—
0
6
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
75
0.93
0.00
2.0
1.3
—
80.6
—
0
5
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
8.7
—
0
6
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
97
0.93
0.00
1.9
1.8
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
198.0
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
10.8
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: D3_IMMUNEMECHANISMOTHER – Other disorders involving the immune mechanism, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).